Serological identification of TROP2 by recombinant cDNA expression cloning using sera of patients with esophageal squamous cell carcinoma

作者: Kazue Nakashima , Hideaki Shimada , Takenori Ochiai , Mari Kuboshima , Namiko Kuroiwa

DOI: 10.1002/IJC.20517

关键词: PathologyAntibodyTACSTD2Molecular biologyTumor markerBiologyEsophageal diseaseHyperplasiaImmunohistochemistryEpithelial cell adhesion moleculeAntigen

摘要: We applied serological analysis of recombinant cDNA expression libraries (SEREX) to cases esophageal squamous cell carcinoma (SCC) identify tumor antigens. One the clones identified was TROP2, which is known as calcium signal transducer. To evaluate clinical significance serum anti-TROP2 antibodies (s-TROP2-Abs) in patients with SCC, presence s-TROP2-Abs analyzed by Western blotting using bacterially expressed TROP2 protein. found that 23 75 (31%) were positive for s-TROP2-Abs. Positivity terms showed a significant association size but not other clinicopathological features. The protein levels much higher SCC lines compared those normal mucosa and its immortalized cells although mRNA necessarily elevated malignant tissues. Immunohistochemical studies specimens noticeably than mild hyperplasia mucosae. Thus, seemed useful diagnosis may be candidate markers.

参考文章(30)
TNM classification of malignant tumours Published in <b>2010</b> in Chichester, West Sussex, UK ;Hoboken, NJ by Wiley-Blackwell. ,(1987) , 10.1007/978-3-642-82982-6
Tetsuro Nishihira, Takashi Akaishi, Katsu Hirayama, Shozo Mori, Yoshiki Kuriya, Morio Kasai, Makoto Suda, Takashi Sasaki, Toshio Watanabe, Michihiko Kitamura, Characteristics of two cell lines (TE-1 and TE-2) derived from human squamous cell carcinoma of the esophagus. GANN Japanese Journal of Cancer Research. ,vol. 70, pp. 575- 584 ,(1979) , 10.20772/CANCERSCI1959.70.5_575
H Shimada, T Hoshino, S Okazumi, H Matsubara, Y Funami, Y Nabeya, H Hayashi, A Takeda, T Shiratori, T Uno, H Ito, T Ochiai, Expression of angiogenic factors predicts response to chemoradiotherapy and prognosis of oesophageal squamous cell carcinoma. British Journal of Cancer. ,vol. 86, pp. 552- 557 ,(2002) , 10.1038/SJ.BJC.6600129
Shigeo Yoshida, Yuji Kumano, Ayako Yoshida, Shin-ichiro Numa, Nobuyuki Yabe, Toshio Hisatomi, Teruo Nishida, Tatsuro Ishibashi, Takao Matsui, Two brothers with gelatinous drop-like dystrophy at different stages of the disease: role of mutational analysis. American Journal of Ophthalmology. ,vol. 133, pp. 830- 832 ,(2002) , 10.1016/S0002-9394(02)01407-1
Alessandro Terrinoni, Roberta Dell'Arciprete, Mara Fornaro, Manuela Stella, Saverio Alberti, Cyclin D1 gene contains a cryptic promoter that is functional in human cancer cells. Genes, Chromosomes and Cancer. ,vol. 31, pp. 209- 220 ,(2001) , 10.1002/GCC.1137
Hideaki Shimada, Yoshihiro Nabeya, Shin-ichi Okazumi, Hisahiro Matsubara, Yutaka Funami, Tooru Shiratori, Hideki Hayashi, Akihiko Takeda, Takenori Ochiai, Prognostic significance of serum p53 antibody in patients with esophageal squamous cell carcinoma Surgery. ,vol. 132, pp. 41- 47 ,(2002) , 10.1067/MSY.2002.125307
Alonzo H. Ross, Dorothee Herlyn, Dimitrios Iliopoulos, Hilary Koprowski, Isolation and characterization of a carcinoma-associated antigen. Biochemical and Biophysical Research Communications. ,vol. 135, pp. 297- 303 ,(1986) , 10.1016/0006-291X(86)90976-9
Hideaki Shimada, Yoshihiro Nabeya, Shin-ichi Okazumi, Hisahiro Matsubara, Tooru Shiratori, Yoshio Gunji, Susumu Kobayashi, Hideki Hayashi, Takenori Ochiai, Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma. Surgery. ,vol. 133, pp. 486- 494 ,(2003) , 10.1067/MSY.2003.139
Hideaki Shimada, Akihiko Takeda, Miwako Arima, Shinichi Okazumi, Hisahiro Matsubara, Yoshihiro Nabeya, Yutaka Funami, Hideki Hayashi, Yoshio Gunji, Takao Suzuki, Susumu Kobayashi, Takenori Ochiai, Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma. Cancer. ,vol. 89, pp. 1677- 1683 ,(2000) , 10.1002/1097-0142(20001015)89:8<1677::AID-CNCR5>3.0.CO;2-9